Two NYC Health & Hospitals facilities are live with Epic after an April 1 go-live that a spokesman for the health system went well, explaining, “There were minor issues, but they were dealt with right away.”
A newly released CMS inspection report confirms that Theranos’ proprietary blood testing analyzer, Edison, failed internal quality control tests 29 percent of the time, while its California lab was also cited for doing tests with unqualified personnel and storing samples at the wrong temperatures.
Proteus Digital Health announces interim results from an RCT study of its smartpill technology, finding that its smartpill technology improves blood pressure control in hypertension patients significantly. 85 percent of patients using the smartpill achieved their target blood pressure within four weeks, while only 33 percent of participants in a control group receiving traditional care were able to do the same.
Michael Hodgkins, MD, CMIO of the American Medical Association, discusses interoperability and his role on the board of the Sequoia Project, formerly Healtheway.